Cardinal Health Launches New Latex-Free Exam Glove
Cardinal Health recently introduced its Flexal Nitrile exam glove that offers the flexibility and barrier protection of a nitrile glove with the tactile sensitivity of a latex one.
Developed in response to customer requests for a strong, comfortable, synthetic glove with the tactility of latex, the Flexal exam glove features a textured-fingertip that provides enhanced sensitivity over traditional nitrile gloves without compromising reliability or durability. As the newest nitrile glove in the Cardinal Health portfolio, Flexal provides a high-quality and cost-effective alternative to latex and nitrile gloves currently available in the market.
"Cardinal Health developed the Flexal Nitrile exam glove to improve a clinicians sense of touch while maintaining confidenc e in its barrier protection," says Lisa Ashby, president of category management for the medical segment of Cardinal Health. "We continue to innovate our product portfolio to provide cost-effective solutions that will help our customers improve the quality of care, and were pleased to offer this alternative in Flexal."
A powder-free addition to Cardinal Healths exam glove portfolio, Flexal complements the Esteem®, Flexam®, InstaGard®, and Triflex® product lines and the Esteem, Duraprene, Protegrity® and Triflex families of Cardinal Health surgical gloves.
Ensuring Safety and Comfort: The Urgent Need for Well-Fitted PPE in Health Care
April 5th 2024Personal protective equipment (PPE) stands as the first line of defense against infectious diseases in health care. Yet, the issue of ill-fitting PPE, especially for women, remains a significant challenge.
COVID-19 Harmonization: Balancing Risks and Benefits of CDC's Latest Move
March 11th 2024The CDC's recent decision to align recommendations for respiratory viruses, particularly COVID-19, has garnered support from the public and infectious disease societies. However, as the Infectious Diseases Society of America (IDSA) lends its backing to the CDC's harmonization efforts, concerns persist regarding the implications of this shift, especially considering the Omicron variant's unique characteristics and the ongoing challenges posed by COVID-19's multi-system impacts.
Voices of Resilience: Q&A With the Editor of "Corona City: Voices From an Epicenter"
March 1st 2024Step into the diverse and poignant world of "Corona City: Voices From an Epicenter" with editor Lorraine Ash, MA. In this insightful Q&A, learn about the origins of this remarkable anthology, the challenges faced in capturing raw, unfiltered narratives of the COVID-19 pandemic, and the lasting impact of these stories on readers and communities alike.
Rare Disease Day 2024: Spotlight on Rare Infectious Diseases
February 29th 2024Rare Disease Day on February 29, 2024, shines a global light on the impact of rare diseases, including rare infectious diseases. With a focus on early diagnosis and treatment access, this day highlights the struggles of those with rare conditions.
